Research Grade Tibulizumab
SKU: BTL-AS-A-16458 |
Host: Humanized |
Brand: Antibody System
Product Description
| Cat Number | DHH28810 |
|---|---|
| Category | Biosimilar Antibody |
| Pack Size | 100 μg |
| Applications | Research Grade Biosimilar |
| Target | CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor |
| Clonality | Monoclonal |
| Clone | Tibulizumab |
| Specificity | Human |
| Synonyms | Bispecific, LY 3090106, LY-3090106, LY3090106, CAS: 1849636-24-3 |
| Host | Humanized |
| Isotype | IgG4-kappa-[scFv]2 |
| Purity | >95% as determined by SDS-PAGE. |
| Storage | 0.01M PBS, pH 7.4. |
| Note | The product is for research use only |
Share Item: